We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

GE Healthcare Launches the illustra™ ExoStar Kit


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GE Healthcare Launches the illustra™ ExoStar Kit"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GE Healthcare’s ExoStar kit supports researchers by providing a high performance and cost effective product for the enzymatic removal of unincorporated primers and nucleotides from PCR and sequencing reactions.

GE Healthcare is dedicated to working with scientists to support lab research by developing innovative, affordable products.

The new ExoStar kit enables efficient primer digestion with no degradation of target PCR products, allowing almost 100% yield of the desired PCR products.

The PCR clean-up product contains two enzymes that have been expressly designed to work together, with one tube of Exonuclease 1 at a concentration of 10U µl-1 and one tube of illustra Alkaline Phosphatase at a concentration of 1U µl-1.

GE Healthcare patented the original enzymatic approach for PCR and sequencing clean-up reactions, with the new ExoStar now providing an advanced performance reformulation.

Advertisement